Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $40.32 |
Previous Close | $40 |
Day Range | $38.69-$41.69 |
52W Range | $11.05-$42.26 |
Market Cap | $1.8B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $20M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $6.8M |
Diluted EPS | -$2.60 |
News
See moreYahoo Finance • 10 days ago
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
Yahoo Finance • 2 months ago
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Yahoo Finance • 3 months ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
Yahoo Finance • 6 months ago
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 99 High Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 84 |